キャンバスの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2014/11/21 | 1,208 | 1,232 | 1,158 | 1,216 | +16 | +1.3% | 93,400 |
| 2014/11/20 | 1,260 | 1,275 | 1,191 | 1,200 | -67 | -5.3% | 134,900 |
| 2014/11/19 | 1,270 | 1,390 | 1,256 | 1,267 | +1 | +0.1% | 265,600 |
| 2014/11/18 | 1,260 | 1,309 | 1,229 | 1,266 | +59 | +4.9% | 157,500 |
| 2014/11/17 | 1,204 | 1,257 | 1,176 | 1,207 | +33 | +2.8% | 137,200 |
| 2014/11/14 | 1,190 | 1,205 | 1,121 | 1,174 | -20 | -1.7% | 99,100 |
| 2014/11/13 | 1,285 | 1,285 | 1,176 | 1,194 | -41 | -3.3% | 129,600 |
| 2014/11/12 | 1,180 | 1,290 | 1,171 | 1,235 | +81 | +7% | 218,600 |
| 2014/11/11 | 1,160 | 1,163 | 1,135 | 1,154 | -6 | -0.5% | 61,200 |
| 2014/11/10 | 1,145 | 1,194 | 1,140 | 1,160 | -15 | -1.3% | 71,000 |
| 2014/11/07 | 1,198 | 1,210 | 1,156 | 1,175 | -32 | -2.7% | 93,000 |
| 2014/11/06 | 1,216 | 1,250 | 1,200 | 1,207 | -67 | -5.3% | 114,500 |
| 2014/11/05 | 1,230 | 1,285 | 1,193 | 1,274 | +44 | +3.6% | 97,800 |
| 2014/11/04 | 1,245 | 1,265 | 1,180 | 1,230 | -6 | -0.5% | 105,000 |
| 2014/10/31 | 1,236 | 1,256 | 1,166 | 1,236 | -30 | -2.4% | 135,000 |
| 2014/10/30 | 1,300 | 1,320 | 1,245 | 1,266 | -20 | -1.6% | 118,600 |
| 2014/10/29 | 1,310 | 1,325 | 1,280 | 1,286 | -69 | -5.1% | 117,000 |
| 2014/10/28 | 1,265 | 1,385 | 1,232 | 1,355 | +50 | +3.8% | 180,100 |
| 2014/10/27 | 1,298 | 1,325 | 1,215 | 1,305 | -26 | -2% | 205,700 |
| 2014/10/24 | 1,352 | 1,375 | 1,301 | 1,331 | -66 | -4.7% | 186,300 |
| 2014/10/23 | 1,409 | 1,480 | 1,310 | 1,397 | -33 | -2.3% | 246,400 |
| 2014/10/22 | 1,610 | 1,625 | 1,250 | 1,430 | -208 | -12.7% | 654,300 |
| 2014/10/21 | 1,418 | 1,640 | 1,387 | 1,638 | +217 | +15.3% | 525,900 |
| 2014/10/20 | 1,435 | 1,520 | 1,385 | 1,421 | -97 | -6.4% | 254,300 |
| 2014/10/17 | 1,500 | 1,578 | 1,408 | 1,518 | +81 | +5.6% | 453,100 |
| 2014/10/16 | 1,260 | 1,520 | 1,211 | 1,437 | +147 | +11.4% | 608,300 |
| 2014/10/15 | 1,100 | 1,378 | 1,095 | 1,290 | +212 | +19.7% | 726,000 |
| 2014/10/14 | 1,040 | 1,110 | 1,009 | 1,078 | -16 | -1.5% | 107,200 |
| 2014/10/10 | 1,144 | 1,144 | 1,031 | 1,094 | +70 | +6.8% | 328,800 |
| 2014/10/09 | 1,039 | 1,070 | 1,008 | 1,024 | -20 | -1.9% | 46,900 |
| 2014/10/08 | 980 | 1,050 | 964 | 1,044 | +27 | +2.7% | 57,800 |
| 2014/10/07 | 1,070 | 1,098 | 1,015 | 1,017 | -54 | -5% | 53,800 |
| 2014/10/06 | 1,055 | 1,107 | 1,044 | 1,071 | +11 | +1% | 50,400 |
| 2014/10/03 | 960 | 1,065 | 960 | 1,060 | +91 | +9.4% | 81,100 |
| 2014/10/02 | 902 | 1,000 | 900 | 969 | +7 | +0.7% | 134,400 |
| 2014/10/01 | 1,034 | 1,034 | 960 | 962 | -88 | -8.4% | 76,100 |
| 2014/09/30 | 1,100 | 1,100 | 990 | 1,050 | -21 | -2% | 130,500 |
| 2014/09/29 | 1,100 | 1,143 | 1,065 | 1,071 | +28 | +2.7% | 91,000 |
| 2014/09/26 | 1,070 | 1,094 | 1,025 | 1,043 | -21 | -2% | 68,200 |
| 2014/09/25 | 1,105 | 1,105 | 1,048 | 1,064 | -13 | -1.2% | 51,600 |
| 2014/09/24 | 1,083 | 1,130 | 1,071 | 1,077 | -17 | -1.6% | 39,600 |
| 2014/09/22 | 1,130 | 1,130 | 1,050 | 1,094 | -36 | -3.2% | 55,500 |
| 2014/09/19 | 1,113 | 1,195 | 1,091 | 1,130 | -6 | -0.5% | 121,100 |
| 2014/09/18 | 1,011 | 1,198 | 1,004 | 1,136 | +111 | +10.8% | 267,800 |
| 2014/09/17 | 1,077 | 1,094 | 1,000 | 1,025 | -52 | -4.8% | 89,700 |
| 2014/09/16 | 1,171 | 1,175 | 1,064 | 1,077 | -55 | -4.9% | 86,800 |
| 2014/09/12 | 1,070 | 1,137 | 1,051 | 1,132 | +49 | +4.5% | 135,300 |
| 2014/09/11 | 1,185 | 1,238 | 1,077 | 1,083 | -120 | -10% | 231,100 |
| 2014/09/10 | 1,201 | 1,249 | 1,111 | 1,203 | -27 | -2.2% | 252,500 |
| 2014/09/09 | 1,149 | 1,375 | 1,107 | 1,230 | +103 | +9.1% | 1,416,000 |
2551～
2600
件表示中 / 3692件
類似銘柄と比較する
現在ご覧いただいている「ＣＡＮＢＡＳ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ＣＡＮＢＡＳ | 103,600円 | - | - | 0.00% | - | 6.63倍 |
|
抗がん剤開発に特化した創薬ベンチャー。主力の膵臓がん治療薬候補は自社開発。導出も模索 |
| アンジェス | 7,800円 | +110.0% | - | 0.00% | - | 12.68倍 |
|
大阪大医学部、森下竜一教授創業の創薬ベンチャー。遺伝子治療薬を核に核酸医薬など開発多彩 |
| 扶桑薬 | 238,800円 | +8.3% | +98.1% | 3.43% | 7.85倍 | 0.54倍 |
|
人工腎臓用透析剤・補液が主軸の製薬中堅、透析剤は国内シェア５割。後発薬や製造受託も展開 |
| ステムリム | 31,700円 | - | - | 0.00% | - | 2.92倍 |
|
大阪大学発バイオベンチャー。損傷細胞の活性化物質を動員、再生を促す「再生誘導医薬」を開発 |
| Ｃｈｏｒｄｉａ | 23,000円 | - | - | 0.00% | - | 4.89倍 |
|
ＲＮＡ制御ストレスを標的とする低分子抗がん薬を開発中。開発品・研究者は武田にルーツ |
市場注目の銘柄
チャート関連のコラム
